ライフサイエンスコーパス: cystoid

1 However, the presence of foveal cystoid change is not significantly associated with post

2 yes were more likely to develop new or worse cystoid changes after the study midpoint (13 surgical ey

3 In total, 35 eyes (11.0%) presented cystoid changes consistent with MME, while 93 (29.2%) sh

4 d for submacular fluid, size and location of cystoid changes, inner segment-outer segment (IS-OS) con

5 lium, pars plana, ora serrata pearl, typical cystoid degeneration (TCD), cystic retinal tuft, meridio

6 gressive disease activity, whereas secondary cystoid degeneration is the most relevant imaging marker

7 both subretinal fluid and posterior retinal cystoid degeneration respectively.

8 both subretinal fluid and posterior retinal cystoid degeneration, a dry macula was obtained in 75% a

9 namely subretinal fluid or posterior retinal cystoid degeneration.

10 might be high in eyes with posterior retinal cystoid degeneration.

11 Diffuse DME showed tVC more often than cystoid DME.

12 ngs included hyperreflective spots (n = 11), cystoid edema (n = 5), and subretinal cleft (n = 6).

13 sity after subtraction of larger vessels and cystoid edema cavities.

14 artifactual interpretation of dark areas as cystoid edema may explain the greater frequency of IRF d

15 Areas of cystoid edema were associated with topographically co-lo

16 Areas of cystoid edema were associated with topographically coloc

17 tomatically detect and quantify intraretinal cystoid fluid (IRC) and subretinal fluid (SRF) was devel

18 ing centers for the presence of intraretinal cystoid fluid (IRC), subretinal fluid (SRF), and pigment

19 morphologic parameters included intraretinal cystoid fluid (IRC), subretinal fluid (SRF), pigment epi

20 This pattern of cystoid fluid accumulation is similar to that seen in di

21 te the efficacy of CAIs on visual acuity and cystoid fluid collections (CFC) in XRLS patients in Dutc

22 Cystoid fluid collections (CFCs) were the first retinal

23 Cystoid fluid collections in the macula were found in 50

24 ophy, characterized primarily by early-onset cystoid fluid collections in the neuroretina, which dist

25 Pneumatosis cystoides interstitialis in the course of chronic graft-

26 Pneumatosis cystoides intestinalis (PCI) is a rare disorder characte

27 Pneumatosis cystoides intestinalis may be due to excessive hydrogen

28 inal deposits, subretinal fibrous scars, and cystoid intraretinal fluid collections in the macula.

29 the OCT detectability of pre-existing foveal cystoid lesions.

30 ner retinal layers, ellipsoid zone (EZ), and cystoid macular changes (CMCs).

31 Cystoid macular changes were found in 53% of patients an

32 of RPE atrophy, and 2 eyes (2.8%) developed cystoid macular degeneration.

33 Dominant cystoid macular dystrophy could be classified into 3 sta

34 Dominant cystoid macular dystrophy is a progressive retinal dystr

35 Postoperative complications included cystoid macular edema (10%), corneal decompensation (6%)

36 cation (50.9%), posterior synechiae (21.7%), cystoid macular edema (16%), epiretinal membrane (13.2%)

37 [4%]), retained cortical fragment (1 [4%]), cystoid macular edema (2 [8%]), and IOL subluxation (3 [

38 ction (4%), corneal decompensation (2%), and cystoid macular edema (2%).

39 glaucoma (4.7%), retinal detachment (4.1%), cystoid macular edema (2.1%), and uveitis (1%) were foun

40 ar hypertension (29 eyes, 10%) and transient cystoid macular edema (25 eyes, 8.6%).

41 ve complications occurred in 5.2%, primarily cystoid macular edema (3.7%).

42 lar thickening (95.3% vs. 51.6%, p < 0.001), cystoid macular edema (36% vs. 11.7%, p < 0.001), subret

43 (11 eyes), iris neovascularization (2 eyes), cystoid macular edema (4 eyes), and hyphema (1 eye).

44 hypertension (12.9%), corneal edema (8.9%), cystoid macular edema (6.9%), and vitreous hemorrhage (5

45 l neovascularization (5%), atrophy (5%), and cystoid macular edema (9%).

46 d with higher rates of complications such as cystoid macular edema (CME) (15% vs. 4%, P < .001), need

47 These included cystoid macular edema (CME) (172 eyes; 0.496%), signific

48 complications were uveal effusion (9.3%) and cystoid macular edema (CME) (7.0%).

49 evaluate the incidence and risk factors for cystoid macular edema (CME) and epiretinal membrane (ERM

50 total images were acquired and evaluated for cystoid macular edema (CME) and persistence of inner ret

51 ibizumab-treated CRVO patients with resolved cystoid macular edema (CME) at month 3, those with persi

52 Cystoid macular edema (CME) before intraocular surgery w

53 s pigmentosa; 37 (21%) of these patients had cystoid macular edema (CME) by OCT.

54 Postoperative cystoid macular edema (CME) developed in 45 eyes (9.6%),

55 Published reports of the occurrence of cystoid macular edema (CME) in eyes being treated with l

56 IDs) are effective in decreasing the risk of cystoid macular edema (CME) in high-risk eyes, but must

57 Current treatments for cystoid macular edema (CME) in retinitis pigmentosa (RP)

58 Cystoid macular edema (CME) in retinitis pigmentosa (RP)

59 However, the risk of postoperative cystoid macular edema (CME) in RP remains unclear.

60 mor thickness (2.9 mm vs. 3.2 mm; P = 0.01), cystoid macular edema (CME) involving the foveola (30% v

61 Cystoid macular edema (CME) is a common problem after ca

62 Cystoid macular edema (CME) is a leading cause of blindn

63 Cystoid macular edema (CME) occurred in 5 eyes (0.87%):

64 ld, with a vitreous haze score of >/=1.5+ or cystoid macular edema (CME) of >300 mum were enrolled.

65 ) in cataract surgery with specific focus on cystoid macular edema (CME) on the basis of expert opini

66 OP), corneal edema, iritis, IOL dislocation, cystoid macular edema (CME) or endophthalmitis, were rep

67 None of patients developed cystoid macular edema (CME) or macular epiretinal membra

68 ral retinal thickness was similar (P = .97); cystoid macular edema (CME) was found in 4 and 5 patient

69 Epiretinal membrane (ERM) and cystoid macular edema (CME) were graded after surgery.

70 sual acuity, intraocular pressure (IOP), and cystoid macular edema (CME) were recorded at each visit.

71 Rates of epiretinal membrane (ERM) and cystoid macular edema (CME) were significantly lower in

72 al acuity (VA), complications, resolution of cystoid macular edema (CME), and anterior chamber and vi

73 inal hard exudates, retinal detachment (RD), cystoid macular edema (CME), and epiretinal membrane (ER

74 ion rates including retinal detachment (RD), cystoid macular edema (CME), and epiretinal membrane for

75 ourse can be complicated by inflammation and cystoid macular edema (CME), and in uveitic patients, in

76 in retinal dystrophy, differentiate it from cystoid macular edema (CME), and review the role of carb

77 mation, best corrected visual acuity (BCVA), cystoid macular edema (CME), and the highest fluorescein

78 lary leakage in 36.4% of eyes without MME or cystoid macular edema (CME), in 39% of eyes with MME, an

79 ntour, persistent fetal foveal architecture, cystoid macular edema (CME), intraretinal exudates and s

80 ase, vitreous opacities, retinal detachment, cystoid macular edema (CME), macular scarring, macular h

81 First diagnosis of (1) epiphora, (2) cystoid macular edema (CME), or (3) optic neuropathy asc

82 uthors retrospectively selected visits where cystoid macular edema (CME), subretinal fluid (SRF), or

83 lar traction, epiretinal membrane (ERM), and cystoid macular edema (CME), were analyzed.

84 pose patients with glaucoma to develop acute cystoid macular edema (CME).

85 with visual acuity (VA) in eyes with uveitic cystoid macular edema (CME).

86 ntraocular pressure (IOP) increase (n = 12), cystoid macular edema (CME; n = 3), and nonarteritic ant

87 In the parous group, 21% had cystoid macular edema (CMO) requiring treatment and 46%

88 Study [ETDRS] of 55 letters or better); (2) cystoid macular edema (CMO), foveal thickness, and macul

89 idence interval {CI}, 2.15-4.35], P < .001), cystoid macular edema (HR = 2.87 [95% CI, 1.41-5.82], P

90 1), retinal neovascularization (n = 1), and cystoid macular edema (n = 1).

91 dialysis (n = 15; 5%) and (exacerbation of) cystoid macular edema (n = 14; 5%), respectively.

92 = 65; 29.4%), cataract (n = 41; 18.5%), and cystoid macular edema (n = 29; 13.1%).

93 less commonly associated with postoperative cystoid macular edema (OR = 0.36, 95% CI: 0.14-0.91, P =

94 lar edema (DME) or postvitrectomy persistent cystoid macular edema (P < .05).

95 no differences between groups when assessing cystoid macular edema (P = .96), retinal detachment (P =

96 AR of BCVA was associated significantly with cystoid macular edema (p = 0.001), ellipsoid zone(p = 0.

97 (2) = 48%; n = 4 studies, 321 participants), cystoid macular edema (P = 0.15; I(2) = 0%; n = 6 studie

98 (P = 0.15), retinal detachments (P = 0.76), cystoid macular edema (P = 0.83), or timing of complicat

99 on between serum biomarkers and pseudophakic cystoid macular edema (PCME) in eyes without risk factor

100 Pseudophakic cystoid macular edema (PCME) is a common cause of visual

101 ification for the prevention of pseudophakic cystoid macular edema (PCME) using a prospective, random

102 At 28 days postsurgery, pseudophakic cystoid macular edema (PCME) was reported in 8 eyes, of

103 afenac 0.3% in the treatment of pseudophakic cystoid macular edema (PCME).

104 ation between drainage technique and risk of cystoid macular edema (PRB 28%, PR 39%, PFCL 46%, P = .0

105 s, dry age-related macular degeneration, and cystoid macular edema (ROR 445, 95% CI 140-1412).

106 The most prevalent change was cystoid macular edema [28 eyes, (17.4%)], followed by ep

107 choroidal hemorrhage, infectious keratitis, cystoid macular edema [CME], retinal detachment [RD], or

108 Cystoid macular edema after cataract surgery has a tende

109 st 1, 2001 and July 31, 2002 on the topic of cystoid macular edema after cataract surgery.

110 um occurred in 100% (15/15); 2) reduction in cystoid macular edema and improvement of outer retinal c

111 valuable for detecting complications such as cystoid macular edema and retinal thinning.

112 Cystoid macular edema and vitreous hyperreflective foci

113 Forty-four eyes had cystoid macular edema at baseline (55%), and 41 eyes (51

114 Eighteen eyes exhibited cystoid macular edema at baseline (56%), and 17 eyes (53

115 OCT showed cystoid macular edema at presentation in 3 patients, whi

116 oherence tomography macula showed parafoveal cystoid macular edema bilaterally.

117 risk of outer retinal band discontinuity and cystoid macular edema compared with PRB or PR.

118 The rate of cystoid macular edema decreased from 22.7% at baseline t

119 Postoperative cystoid macular edema developed in 6.9% of RP eyes and 1

120 Cystoid macular edema did not occur as a postoperative c

121 ave been shown to be effective in preventing cystoid macular edema following cataract surgery or trea

122 Other complications included cystoid macular edema in 1 eye (2.4%), posterior synechi

123 re a transient IOP spike in 8 (17%) eyes and cystoid macular edema in 6 eyes (13%).

124 OCT on presentation demonstrated cystoid macular edema in 8 of 20 eyes and symptomatic vi

125 t underlying pathophysiologic foundation for cystoid macular edema in retinal vascular diseases.

126 Cystoid macular edema in retinal vein occlusion occurred

127 form changes that were hyperautofluorescent, cystoid macular edema in the inner nuclear layer, no lig

128 Four eyes (12%) had cystoid macular edema in the repositioning group compare

129 Pseudophakic cystoid macular edema is an important cause of visual de

130 Pseudophakic cystoid macular edema is common after phacoemulsificatio

131 Usually vision loss from cystoid macular edema is temporary and responds to treat

132 Cystoid macular edema may be more likely to develop in p

133 rradiation and intravitreal therapy to treat cystoid macular edema not originating from the optic dis

134 Cystoid macular edema observed on SD OCT in very preterm

135 nd optical coherence tomography (OCT) showed cystoid macular edema on both eyes.

136 edema following cataract surgery or treating cystoid macular edema once it occurs.

137 subclinical susceptibility to postoperative cystoid macular edema or exacerbation of choroidal neova

138 Diagnosis of cystoid macular edema or new-onset macular edema in pati

139 Cystoid macular edema persisted in 9 of 11 eyes affected

140 Cystoid macular edema refractory to carbonic anhydrase i

141 Cystoid macular edema seems to be a marker for poorer vi

142 Cystoid macular edema was common in those with preserved

143 The risk for the development of cystoid macular edema was found to be associated with re

144 ly [P = .001]), whereas an increased risk of cystoid macular edema was not identified for those who r

145 In one eye, development of cystoid macular edema was observed before the outer reti

146 No cystoid macular edema was observed in the control group.

147 Cystoid macular edema was present in 9, 1, 5, 9, and 1 p

148 Cystoid macular edema was seen in 25 of the 46 patients

149 Compared with ACIOL, complications of cystoid macular edema were higher in 10-0 polypropylene

150 r chamber and vitreous cell, and presence of cystoid macular edema were obtained from the medical cha

151 20/13 to 20/40(+2), except in 1 patient with cystoid macular edema whose vision was 20/60(-) and 20/7

152 vascular plexus were analyzed in relation to cystoid macular edema with retention of depth informatio

153 acy (for both postoperative inflammation and cystoid macular edema) without the typically corticoster

154 m was associated with a higher prevalence of cystoid macular edema, active uveitis, and optic disc sw

155 Twenty-seven eyes had cystoid macular edema, and 10 eyes had diffuse macular e

156 f vision loss, including retinal detachment, cystoid macular edema, and optic neuropathy.

157 corneal edema, intraocular pressure spikes, cystoid macular edema, and posterior capsule opacificati

158 Rates of immune recovery uveitis, new-onset cystoid macular edema, and retinal detachment were 0%, 1

159 topathy, trace to 2+ anterior chamber cells, cystoid macular edema, and retinal vasculitis on fluores

160 ised sponge-like diffuse retinal thickening, cystoid macular edema, and serous retinal detachment.

161 ch may include pseudocysts, macular schisis, cystoid macular edema, and subretinal fluid.

162 eyes and seven eyes with retinal pathology (cystoid macular edema, central serous retinopathy, vitre

163 result in different complications including cystoid macular edema, endophthalmitis, glaucoma, and co

164 multiple processes, including postoperative cystoid macular edema, epiretinal membrane formation, ma

165 Anterior uveitis, cataract, vitritis, cystoid macular edema, epiretinal membrane, and disc ede

166 done for all eyes assessing the presence of cystoid macular edema, epiretinal membrane, macular hole

167 nd perimeter in ICP and DCP, and presence of cystoid macular edema, HE, and cataract were higher in e

168 ewed OCT scans to determine the type of DME, cystoid macular edema, or diffuse macular edema (absence

169 y related to visual acuity, age, presence of cystoid macular edema, or subjects' stress or anxiety le

170 s with dark irides had a higher incidence of cystoid macular edema, PCE, and rebound inflammation in

171 Older subjects were more likely to develop cystoid macular edema, raised intraocular pressure and c

172 , any occurrence of immune recovery uveitis, cystoid macular edema, retinal detachment, or a combinat

173 ressure control, worsening of visual acuity, cystoid macular edema, retroprosthetic membrane formatio

174 as assessed by multiadjusted odds of retinal cystoid macular edema, was not increased for patients re

175 rneal edema (PCE), rebound inflammation, and cystoid macular edema, were compared between the 2 group

176 Cystoid macular edema, which was present in 40 eyes at b

177 n the central macula with or without typical cystoid macular edema.

178 1 day of treatment, and 1 patient developed cystoid macular edema.

179 ery-associated retinal complications such as cystoid macular edema.

180 s whether NSAIDS can reduce the incidence of cystoid macular edema.

181 ement of both postoperative inflammation and cystoid macular edema.

182 lar hole, diabetic retinopathy, uveitis, and cystoid macular edema.

183 can lead to retinal disease de novo, such as cystoid macular edema.

184 seudotumor cerebri, thyroid orbitopathy, and cystoid macular edema.

185 eitis-glaucoma-hyphema syndrome, and chronic cystoid macular edema.

186 ases, suboptimal visual results secondary to cystoid macular edema.

187 al anterior synechiae, or known or suspected cystoid macular edema.

188 g anterior chamber reactions, and inhibiting cystoid macular edema.

189 33% of patients developed cystoid macular edema.

190 pensation, glaucoma, retinal detachment, and cystoid macular edema.

191 with MME, while 93 (29.2%) showed "typical" cystoid macular edema.

192 eyes experienced more frequent postoperative cystoid macular edema.

193 lmitis, or intermediate/posterior uveitis or cystoid macular edema.

194 d thickness (CST) over time, and presence of cystoid macular edema.

195 al contour, in some cases "stage 0" ROP, and cystoid macular edema.

196 omplication recorded after PPV was a case of cystoid macular edema.

197 thickness in RP patients with no history of cystoid macular edema.

198 ghteen of the 61 eyes (29.5%) also developed cystoid macular edema.

199 xime as measured by the incidence of POE and cystoid macular edema.

200 ar degeneration, vitreomacular traction, and cystoid macular edema.

201 xel may cause ocular adverse effects such as cystoid macular edema.

202 lvement; intraocular inflammation, including cystoid macular edema; and retinal degeneration.

203 The aim of this study is to report a case of cystoid macular oedema (CME) associated with Rosai-Dorfm

204 To report the rate of cystoid macular oedema (CMO) as detected by spectral-dom

205 treat-and-extend protocol of aflibercept for cystoid macular oedema (CMO) secondary to central retina

206 il tamponade (elevated intraocular pressure, cystoid macular oedema (CMO), cataract and posterior cap

207 such as anterior uveitis, were rare and any cystoid macular oedema was transient.

208 re still remain risks of retinal detachment, cystoid macular oedema, glare, halos and posterior capsu

209 with a scleral nodule, anterior uveitis and cystoid macular oedema.

210 The treated eye of one child developed cystoid macular oedema.

211 e first reported case of RDD associated with cystoid macular oedema.

212 Recent case reports have suggested that cystoid maculopathy (CM) could affect CS patients with a

213 level of the retinal pigment epithelium and cystoid or schisis-like maculopathy with typical functio

214 poreflective intraretinal spaces, indicating cystoid or schitic fluid, were seen in ora serrata pearl

215 ures included subretinal fluid (n = 9; 19%), cystoid retinal edema (n = 6; 13%), retinal traction (n

216 e tissue area index (MTAI), and macular hole cystoid space area index (MCSAI), were recorded.

217 SD-OCT showed cystoid space in the macular region of both eyes as well

218 ecovered and the presence of glial cells and cystoid space resolved gradually after surgery.

219 Tractional intraretinal cystoid spaces (24/72 eyes, 33.3%), displayed a radial "

220 Exudative intraretinal cystoid spaces (36/72 eyes, 50%) displayed a "petaloid"

221 xi peaks (5% vs 88%, P < .001), intraretinal cystoid spaces (72% vs 40%, P < .038), outer plexiform l

222 ckness was significantly lower in tractional cystoid spaces (P < .001).

223 Cystoid spaces accounting for macular splitting were pre

224 ed in relation to structural changes such as cystoid spaces and disorganization of the retinal inner

225 hort of patients diagnosed with intraretinal cystoid spaces and imaged with optical coherence tomogra

226 The structural OCT data were segmented for cystoid spaces and integrated into the angiographic data

227 ontrast, eyes with baseline central subfield cystoid spaces and/or subretinal fluid showed more impro

228 Exudative and tractional intraretinal cystoid spaces displayed characteristic multimodal imagi

229 uid (SRF) in 20 of 30 eyes (67%) and retinal cystoid spaces in 11 of 30 eyes (37%).

230 e signs emerged (SRF in 3/6 eyes and retinal cystoid spaces in 5/6 eyes).

231 There were a greater number of INL cystoid spaces in both the exudative and FTMH subgroups

232 One patient showed a moderate decrease of cystoid spaces in the absence of treatment at 22 years o

233 uding JR, patient characteristics, number of cystoid spaces in the INL, INL area, and outer retina ar

234 n presence of small, nonconfluent elliptical cystoid spaces located at the level of the inner nuclear

235 integrity was restored in 54 eyes (62%), and cystoid spaces of variable severity were observed in 28

236 tegrity and the presence of central subfield cystoid spaces or subretinal fluid each predict improved

237 elative analysis we found that the volume of cystoid spaces was positively correlated to the thicknes

238 The surface area of INL cystoid spaces was significantly lower in the tractional

239 rnal limiting membrane (ELM) and presence of cystoid spaces were evaluated using spectral-domain (SD)

240 Intraretinal cystoid spaces were observed in 34 eyes (68%) using FA,

241 The GCL/FNL cystoid spaces were small and seen near the fovea and th

242 subretinal fluid, intraretinal fluid, and/or cystoid spaces); (2) evidence of CNV activity on FFA ide

243 d patients by submacular fluid, intraretinal cystoid spaces, and renal disease.

244 AF features of both exudative and tractional cystoid spaces, but without any FA leakage.

245 -thickness retinal involvement, intraretinal cystoid spaces, ellipsoid zone disruption, RPE disruptio

246 ormal thinning volume, intraretinal fluid or cystoid spaces, hyperreflective foci, and RPE layer atro

247 Loss of macular pigment, cystoid spaces, pigment plaques, neovascular membranes,

248 nd by poor baseline BCVA, large intraretinal cystoid spaces, renal disease, and absence of hyperchole

249 ed with RAP showed the highest percentage of cystoid spaces.

250 s (CAI) was provided to reduce the volume of cystoid spaces.